Dynamic Technology Lab Private Ltd purchased a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH – Free Report) during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm purchased 22,380 shares of the company’s stock, valued at approximately $701,000.
A number of other large investors have also bought and sold shares of the stock. Harbor Capital Advisors Inc. grew its holdings in shares of Option Care Health by 317.9% in the second quarter. Harbor Capital Advisors Inc. now owns 96,375 shares of the company’s stock worth $2,670,000 after purchasing an additional 73,312 shares during the last quarter. Global Alpha Capital Management Ltd. boosted its position in Option Care Health by 108.3% during the 3rd quarter. Global Alpha Capital Management Ltd. now owns 49,818 shares of the company’s stock valued at $1,559,000 after buying an additional 25,905 shares during the period. Westfield Capital Management Co. LP grew its holdings in Option Care Health by 10.2% in the 3rd quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company’s stock worth $203,204,000 after acquiring an additional 599,589 shares during the last quarter. Janus Henderson Group PLC increased its position in shares of Option Care Health by 182.9% in the first quarter. Janus Henderson Group PLC now owns 227,135 shares of the company’s stock valued at $7,617,000 after acquiring an additional 146,837 shares during the period. Finally, Victory Capital Management Inc. raised its stake in shares of Option Care Health by 4,432.8% during the third quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company’s stock valued at $50,756,000 after acquiring an additional 1,585,818 shares during the last quarter. 98.05% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Several analysts recently issued reports on the company. Barrington Research cut their target price on Option Care Health from $40.00 to $32.00 and set an “outperform” rating on the stock in a research note on Thursday, October 31st. JMP Securities boosted their target price on Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a research note on Monday, September 30th. The Goldman Sachs Group downgraded Option Care Health from a “buy” rating to a “neutral” rating and decreased their target price for the company from $38.00 to $27.00 in a report on Monday, November 4th. Jefferies Financial Group cut shares of Option Care Health from a “buy” rating to a “hold” rating and cut their price target for the company from $38.00 to $26.00 in a report on Thursday, October 31st. Finally, Bank of America lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and decreased their price objective for the stock from $43.00 to $29.00 in a report on Wednesday, October 30th. Three analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, Option Care Health has a consensus rating of “Moderate Buy” and a consensus target price of $30.83.
Insider Activity
In related news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of the company’s stock in a transaction dated Friday, November 8th. The shares were purchased at an average cost of $22.54 per share, with a total value of $969,220.00. Following the transaction, the director now directly owns 326,334 shares in the company, valued at $7,355,568.36. This trade represents a 15.18 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.64% of the company’s stock.
Option Care Health Price Performance
Shares of OPCH stock opened at $23.76 on Friday. The business’s fifty day moving average is $27.00 and its 200 day moving average is $28.93. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The stock has a market cap of $4.04 billion, a price-to-earnings ratio of 19.97, a PEG ratio of 2.42 and a beta of 1.32. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $34.63.
About Option Care Health
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Further Reading
- Five stocks we like better than Option Care Health
- What is Put Option Volume?
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- What is the Nasdaq? Complete Overview with History
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH – Free Report).
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.